Airfinity uses a unique quantitative approach that combines advanced meta science and statistics, large language models, epidemiology, and dynamic machine learning solutions to understand true disease prevalence and underlying outcome drivers as they evolve. 

By building AI and large-scale simulation model forecasts focusing on the predictive indicators that could significantly impact disease burden, we can help provide a more nuanced and holistic view of the changing landscape, including any ‘blind spots’ your organization or the industry might have. 

Airfinity is continuously refining its models, diversifying its data sets, and expanding its disease coverage to ensure our team produces the highest quality intelligence and predictions. 

Schedule a free session with our quant analysts to better understand how Airfinity deploys these different technologies within your disease or therapy area of focus.